Other

Sale of investments

Gilead Sciences Sale of investments increased by 641.2% to $2.52B in Q1 2026 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Sale of investments shows an upward trend with a 5.4% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ1 2026May 7, 2026

How to read this metric

High proceeds may indicate active portfolio rebalancing or a strategy to lock in investment gains.

Detailed definition

Represents the cash inflows from the sale of debt securities classified as available-for-sale. This reflects the company...

Peer comparison

Standard metric for insurance companies with large investment portfolios.

Metric ID: other_proceeds_from_sale_of_available_for_sale_securities_debt

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$191.00M$255.00M$224.00M$119.00M$204.00M$47.00M$42.00M$167.00M$150.00M$95.00M$98.00M$2.27B$0.00$295.00M$219.00M$340.00M$2.52B
QoQ Change+33.5%-12.2%-46.9%+71.4%-77.0%-10.6%+297.6%-10.2%-36.7%+3.2%>999%-100.0%-25.8%+55.3%+641.2%
YoY Change+6.8%-81.6%-81.3%+40.3%-26.5%+102.1%+133.3%>999%-100.0%
Range$0.00$2.52B
CAGR+90.6%
Avg YoY Growth+138.8%
Median YoY Growth+6.8%
Current Streak2 quarters growth

Sale of investments at Other Companies

Frequently Asked Questions

What is Gilead Sciences's sale of investments?
Gilead Sciences (GILD) reported sale of investments of $2.52B in Q1 2026.
What is the long-term trend for Gilead Sciences's sale of investments?
Over 3 years (2021 to 2025), Gilead Sciences's sale of investments has grown at a 5.4% compound annual growth rate (CAGR), from $730.00M to $854.00M.
What does sale of investments mean?
Cash received from selling debt investments held in the portfolio.